Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Eflornithine × 30 days × Clear all

Sponsor

Conditions

Neuroblastoma 3 Neuroectodermal Tumors, Primitive 2 Medulloblastoma 2 Typical Teratoid Rhabdoid Tumor 1 Sarcoma, Ewing 1 Rhabdoid Tumor 1 Osteosarcoma 1 Melanoma 1 Lung Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

pembrolizumab 9 Cisplatin 7 Radiotherapy 5 Carboplatin 5 Human Papillomavirus DNA Tests 4 Gemcitabine 4 Fulvestrant 4 Bevacizumab 4 zimberelimab 3 tisotumab vedotin 3 Specimen Handling 3 Restraint, Physical 3 Paclitaxel 3 Magnetic Resonance Spectroscopy 3 Colposcopy 3 Brachytherapy 3 spartalizumab 2 lenvatinib 2 Vinorelbine 2 Topotecan 2 Radiation 2 Platinum 2 Pemetrexed 2 Nivolumab 2 Irinotecan 2 Drug Therapy 2 Biopsy 2 1,2-diaminocyclohexaneplatinum II citrate 2 trastuzumab deruxtecan 1 toripalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡